• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管缺陷与遗传性出血性毛细血管扩张症相关,在 3D 芯片血管中的患者来源同基因 iPSC 中得以揭示。

Vascular defects associated with hereditary hemorrhagic telangiectasia revealed in patient-derived isogenic iPSCs in 3D vessels on chip.

机构信息

Department of Anatomy and Embryology, Leiden University Medical Center, Leiden 2333ZA, the Netherlands.

Department of Anatomy and Embryology, Leiden University Medical Center, Leiden 2333ZA, the Netherlands.

出版信息

Stem Cell Reports. 2022 Jul 12;17(7):1536-1545. doi: 10.1016/j.stemcr.2022.05.022. Epub 2022 Jun 30.

DOI:10.1016/j.stemcr.2022.05.022
PMID:35777360
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9287680/
Abstract

Hereditary hemorrhagic telangiectasia (HHT) is a genetic disease characterized by weak blood vessels. HHT1 is caused by mutations in the ENDOGLIN (ENG) gene. Here, we generated induced pluripotent stem cells (hiPSCs) from a patient with rare mosaic HHT1 with tissues containing both mutant (ENG) and normal cells, enabling derivation of isogenic diseased and healthy hiPSCs, respectively. We showed reduced ENG expression in HHT1 endothelial cells (HHT1-hiPSC-ECs), reflecting haploinsufficiency. HHT1-hiPSC-ECs and the healthy isogenic control behaved similarly in two-dimensional (2D) culture, forming functionally indistinguishable vascular networks. However, when grown in 3D organ-on-chip devices under microfluidic flow, lumenized vessels formed in which defective vascular organization was evident: interaction between inner ECs and surrounding pericytes was decreased, and there was evidence for vascular leakage. Organs on chip thus revealed features of HHT in hiPSC-derived blood vessels that were not evident in conventional 2D assays.

摘要

遗传性出血性毛细血管扩张症(HHT)是一种以血管脆弱为特征的遗传病。HHT1 是由 ENG(内皮糖蛋白)基因突变引起的。在这里,我们从一位罕见的镶嵌型 HHT1 患者的组织中生成了诱导多能干细胞(hiPSC),这些组织中同时包含突变(ENG)和正常细胞,从而分别衍生出同基因的患病和健康 hiPSC。我们发现 HHT1 内皮细胞(HHT1-hiPSC-EC)中的 ENG 表达减少,反映出杂合不足。HHT1-hiPSC-EC 和健康的同基因对照在二维(2D)培养中表现相似,形成功能上无法区分的血管网络。然而,当在微流控下的 3D 器官芯片设备中生长时,形成了有腔的血管,其中明显存在血管组织缺陷:内皮细胞(EC)之间的相互作用减少,并且存在血管渗漏的证据。因此,器官芯片揭示了 hiPSC 衍生的血管中存在 HHT 的特征,而这些特征在传统的 2D 测定中并不明显。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eff9/9287680/69a148f8f143/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eff9/9287680/364820c31e93/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eff9/9287680/ef3315c39528/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eff9/9287680/8f5aee846ea3/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eff9/9287680/de205d05cb0d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eff9/9287680/69a148f8f143/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eff9/9287680/364820c31e93/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eff9/9287680/ef3315c39528/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eff9/9287680/8f5aee846ea3/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eff9/9287680/de205d05cb0d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eff9/9287680/69a148f8f143/gr4.jpg

相似文献

1
Vascular defects associated with hereditary hemorrhagic telangiectasia revealed in patient-derived isogenic iPSCs in 3D vessels on chip.血管缺陷与遗传性出血性毛细血管扩张症相关,在 3D 芯片血管中的患者来源同基因 iPSC 中得以揭示。
Stem Cell Reports. 2022 Jul 12;17(7):1536-1545. doi: 10.1016/j.stemcr.2022.05.022. Epub 2022 Jun 30.
2
Mutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1.影响内皮糖蛋白近端启动子的突变作为1型遗传性出血性毛细血管扩张症的起源。
BMC Med Genet. 2017 Feb 23;18(1):20. doi: 10.1186/s12881-017-0380-0.
3
Overexpression of Activin Receptor-Like Kinase 1 in Endothelial Cells Suppresses Development of Arteriovenous Malformations in Mouse Models of Hereditary Hemorrhagic Telangiectasia.激活素受体样激酶 1 在血管内皮细胞中的过表达抑制遗传性出血性毛细血管扩张症小鼠模型中动静脉畸形的发展。
Circ Res. 2020 Oct 9;127(9):1122-1137. doi: 10.1161/CIRCRESAHA.119.316267. Epub 2020 Jul 31.
4
The ENG/VEGFα Pathway Is Likely Affected by a Nonsense Variant of Endoglin (ENG)/CD105, Causing Hereditary Hemorrhagic Telangiectasia Type 1 (HHT1) in a Chinese Family.ENG/VEGFα 通路可能受内皮糖蛋白(ENG)/CD105 无义变异的影响,导致一个中国家族发生遗传性出血性毛细血管扩张症 1 型(HHT1)。
Genes (Basel). 2024 Feb 27;15(3):304. doi: 10.3390/genes15030304.
5
Endoglin mutants retained in the endoplasmic reticulum exacerbate loss of function in hereditary hemorrhagic telangiectasia type 1 (HHT1) by exerting dominant negative effects on the wild type allele.内质网中滞留的内皮糖蛋白突变体通过对野生型等位基因产生显性负效应,加剧了遗传性出血性毛细血管扩张症 1 型(HHT1)的功能丧失。
Traffic. 2024 Jan;25(1):e12928. doi: 10.1111/tra.12928.
6
Common and distinctive pathogenetic features of arteriovenous malformations in hereditary hemorrhagic telangiectasia 1 and hereditary hemorrhagic telangiectasia 2 animal models--brief report.遗传性出血性毛细血管扩张症1型和2型动物模型中动静脉畸形的共同和独特发病机制特征——简要报告
Arterioscler Thromb Vasc Biol. 2014 Oct;34(10):2232-6. doi: 10.1161/ATVBAHA.114.303984. Epub 2014 Jul 31.
7
PI3K (Phosphatidylinositol 3-Kinase) Activation and Endothelial Cell Proliferation in Patients with Hemorrhagic Hereditary Telangiectasia Type 1.1 型遗传性出血性毛细血管扩张症患者的 PI3K(磷脂酰肌醇 3-激酶)激活与血管内皮细胞增殖。
Cells. 2019 Aug 24;8(9):971. doi: 10.3390/cells8090971.
8
Mutation study of Spanish patients with hereditary hemorrhagic telangiectasia and expression analysis of Endoglin and ALK1.西班牙遗传性出血性毛细血管扩张症患者的突变研究及内皮糖蛋白和激活素受体样激酶1的表达分析
Hum Mutat. 2006 Mar;27(3):295. doi: 10.1002/humu.9413.
9
Genotype-phenotype correlation in hereditary hemorrhagic telangiectasia: mutations and manifestations.遗传性出血性毛细血管扩张症的基因型-表型相关性:突变与表现
Am J Med Genet A. 2006 Mar 1;140(5):463-70. doi: 10.1002/ajmg.a.31101.
10
Non-invasive CT screening for pulmonary arteriovenous malformations in children with confirmed hereditary hemorrhagic telangiectasia: Results from two pediatric centers.对确诊为遗传性出血性毛细血管扩张症的儿童进行非侵入性CT筛查肺动静脉畸形:两个儿科中心的结果
Pediatr Pulmonol. 2017 May;52(5):642-649. doi: 10.1002/ppul.23649. Epub 2017 Feb 6.

引用本文的文献

1
Common and distinct circulating microRNAs in four neurovascular disorders.四种神经血管疾病中常见和独特的循环微小RNA
Biochem Biophys Rep. 2025 Aug 2;43:102189. doi: 10.1016/j.bbrep.2025.102189. eCollection 2025 Sep.
2
The Role of Somatic Mutation in Hereditary Hemorrhagic Telangiectasia Pathogenesis.体细胞突变在遗传性出血性毛细血管扩张症发病机制中的作用。
J Clin Med. 2025 Jun 24;14(13):4479. doi: 10.3390/jcm14134479.
3
Somatic mutations in arteriovenous malformations in hereditary hemorrhagic telangiectasia support a bi-allelic two-hit mutation mechanism of pathogenesis.

本文引用的文献

1
Engineered 3D vessel-on-chip using hiPSC-derived endothelial- and vascular smooth muscle cells.使用 hiPSC 衍生的内皮细胞和血管平滑肌细胞构建 3D 工程化血管芯片。
Stem Cell Reports. 2021 Sep 14;16(9):2159-2168. doi: 10.1016/j.stemcr.2021.08.003. Epub 2021 Sep 2.
2
Hereditary Haemorrhagic Telangiectasia, an Inherited Vascular Disorder in Need of Improved Evidence-Based Pharmaceutical Interventions.遗传性出血性毛细血管扩张症,一种需要改进基于证据的药物干预的遗传性血管疾病。
Genes (Basel). 2021 Jan 27;12(2):174. doi: 10.3390/genes12020174.
3
Oral itraconazole for epistaxis in hereditary hemorrhagic telangiectasia: a proof of concept study.
遗传性出血性毛细血管扩张症动静脉畸形中的体细胞突变支持发病机制的双等位基因两次打击突变机制。
Am J Hum Genet. 2024 Oct 3;111(10):2283-2298. doi: 10.1016/j.ajhg.2024.08.020. Epub 2024 Sep 18.
4
Self-assembling 3D vessel-on-chip model with hiPSC-derived astrocytes.具有人诱导多能干细胞源性星形胶质细胞的自组装 3D 芯片血管模型。
Stem Cell Reports. 2024 Jul 9;19(7):946-956. doi: 10.1016/j.stemcr.2024.05.006. Epub 2024 Jun 13.
5
Employment of diverse in vitro systems for analyzing multiple aspects of disease, hereditary hemorrhagic telangiectasia (HHT).使用多种体外系统分析疾病(遗传性出血性毛细血管扩张症,即HHT)的多个方面。
Cell Biosci. 2024 May 22;14(1):65. doi: 10.1186/s13578-024-01247-z.
6
Mutations causing premature termination codons discriminate and generate cellular and clinical variability in HHT.导致提前终止密码子的突变可区分并产生 HHT 的细胞和临床变异性。
Blood. 2024 May 30;143(22):2314-2331. doi: 10.1182/blood.2023021777.
7
Vascular organs-on-chip made with patient-derived endothelial cells: technologies to transform drug discovery and disease modeling.基于患者来源的内皮细胞的血管类器官芯片:用于转化药物发现和疾病建模的技术。
Expert Opin Drug Discov. 2024 Mar;19(3):339-351. doi: 10.1080/17460441.2023.2294947. Epub 2023 Dec 20.
8
Patient-Derived Microphysiological Systems for Precision Medicine.用于精准医学的患者源性微生理系统
Adv Healthc Mater. 2024 Mar;13(7):e2303161. doi: 10.1002/adhm.202303161. Epub 2023 Dec 10.
9
Using biophysical cues and biomaterials to improve genetic models.利用生物物理线索和生物材料改进遗传模型。
Curr Opin Biomed Eng. 2023 Dec;28. doi: 10.1016/j.cobme.2023.100502. Epub 2023 Sep 9.
10
Vascular organoids: unveiling advantages, applications, challenges, and disease modelling strategies.血管类器官:揭示优势、应用、挑战和疾病建模策略。
Stem Cell Res Ther. 2023 Oct 10;14(1):292. doi: 10.1186/s13287-023-03521-2.
口服伊曲康唑治疗遗传性出血性毛细血管扩张症鼻出血:概念验证研究。
Angiogenesis. 2021 May;24(2):379-386. doi: 10.1007/s10456-020-09758-2. Epub 2020 Nov 19.
4
Generation and genetic repair of 2 iPSC clones from a patient bearing a heterozygous c.1120del18 mutation in the ACVRL1 gene leading to Hereditary Hemorrhagic Telangiectasia (HHT) type 2.从一名患有导致2型遗传性出血性毛细血管扩张症(HHT)的ACVRL1基因杂合c.1120del18突变的患者中生成2个诱导多能干细胞(iPSC)克隆并进行基因修复。
Stem Cell Res. 2020 Jul;46:101786. doi: 10.1016/j.scr.2020.101786. Epub 2020 May 28.
5
Pericytes in Hereditary Hemorrhagic Telangiectasia.遗传性出血性毛细血管扩张症中的周细胞。
Adv Exp Med Biol. 2019;1147:215-246. doi: 10.1007/978-3-030-16908-4_10.
6
3D self-organized microvascular model of the human blood-brain barrier with endothelial cells, pericytes and astrocytes.具有内皮细胞、周细胞和星形胶质细胞的人血脑屏障 3D 自组织微血管模型。
Biomaterials. 2018 Oct;180:117-129. doi: 10.1016/j.biomaterials.2018.07.014. Epub 2018 Jul 12.
7
Inflammatory Responses and Barrier Function of Endothelial Cells Derived from Human Induced Pluripotent Stem Cells.人诱导多能干细胞衍生的内皮细胞的炎症反应和屏障功能。
Stem Cell Reports. 2018 May 8;10(5):1642-1656. doi: 10.1016/j.stemcr.2018.03.012. Epub 2018 Apr 12.
8
Endothelial cell biology of Endoglin in hereditary hemorrhagic telangiectasia.遗传性出血性毛细血管扩张症中内皮糖蛋白的内皮细胞生物学。
Curr Opin Hematol. 2018 May;25(3):237-244. doi: 10.1097/MOH.0000000000000419.
9
Genetic compensation: A phenomenon in search of mechanisms.基因补偿:一种尚待探寻作用机制的现象。
PLoS Genet. 2017 Jul 13;13(7):e1006780. doi: 10.1371/journal.pgen.1006780. eCollection 2017 Jul.
10
Endoglin controls blood vessel diameter through endothelial cell shape changes in response to haemodynamic cues.内皮糖蛋白通过内皮细胞形状变化响应血流动力学信号来控制血管直径。
Nat Cell Biol. 2017 Jun;19(6):653-665. doi: 10.1038/ncb3528. Epub 2017 May 22.